CAROLINE IRBY: Open Payments
NPI 1922711944 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 19 payments from 11 companies in 2025. Trend: 2023 $101 · 2024 $511 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Solventum Corporation | 4 | $176 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $76 |
| ConvaTec Inc. | 2 | $74 |
| Davol Inc. | 1 | $53 |
| Hydrofera LLC | 2 | $40 |
| Integra LifeSciences Corporation | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| CONMED Corporation | 1 | $22 |
| Reprise Biomedical, Inc. | 1 | $20 |
Products named: V.A.C. VERAFLO CLEANSE CHOICE, FARXIGA, JOURNAVX, Phasix Mesh, AQUACEL AG+ EXTRA, AQUACEL FOAM, Integra, HYDROFERA BLUE.
Industry payments across MS — which companies pay providers there.
